1. |
Love RR. The national surgical adjuvant breast project (NSAB) breast cancer prevention trial revisited. Cancer Epidemiol Biomarkers Prev, 1993; 2(5)∶403.
|
2. |
Elias EG, Brown SD, Buda BS, et al. Breast cancer prevention trial. Md Med J, 1994; 43(3)∶249.
|
3. |
Singletary K, MacDonald C, Wallig M. The plasticizer benzyl butyl phthalate (BBP) inhibits 7, 12dimethylbenz[a]anthracene (DMBA)induced rat mammary DNA adduct formation and tumor igenesis. Carcinogenesis, 1997; 18(8)∶1669.
|
4. |
Fahrig R. Antimutagenic agents are also corecombinogenic and can be converted into comutagens. Mutat Res, 1996; 350(1)∶59.
|
5. |
Welsch CW, House JL, Herr BL, et al. Enhancement of mammary carcinogenesis by high levels of dietary fat∶a phenomenon dependent on adlibitum feeding. J Natl Cancer Inst, 1990; 82(20)∶1615.
|
6. |
Arif JM, Smith WA, Gupta RC. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo [a, l]pyrene, 7, 12 dimethylbenz [a] anthracene and benzo [a] pyrene. Mutat Res, 1997; 378(1)∶31.
|
7. |
Ramesha A, Rao N, Rao AR, et al. Chemoprevention of 7, 12dimethylbenz [a] anthracene induced mammary carcinogenesis in rat by the combined actions of selenium, magnesium, ascorbi acid and retinyl acetate. Jpn J Cancer Res, 1990; 81(12)∶1239.
|
8. |
Tsubura A, Izuuo Y, Shoji T, et al. Influence of strain and sex on the local development of mammary tumors induced by direct application of DMBA powder to rat mammary glands. Acta Pathol Jpn, 1990; 40(1)∶9.
|
9. |
Lu J, Pei H, Kaeck M, et al. Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog, 1997; 20(2)∶204.
|
10. |
Manjanatha MG, Chen JB, Shaddock JG Jr, et al. Molecular analysis of lacⅠ mutations in Rat 2 cells exposed to 7, 12dimethylbenz [a] anthracene:evidence for DNA sequence and DNA strand biases for mutation. Mutat Res, 1996; 372(1)∶53.
|
11. |
Kito K, Kihana T, Sugita A, et al. Incidence of p53 and Haras gene mutations in chemically induced rat mammary carcinomas. Mol Carcinog, 1996; 17(2)∶78.
|
12. |
Nagao M, Ushijima T, Toyota M, et al. Genetic changes induced by heterocyclic amines. Mutat Res, 1997; 376(1)∶161.
|
13. |
Ichikawa T, Kyprianou N, Isaacs JT. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following vHras oncogene transfection. Cancer Res, 1990; 50(19)∶6349.
|
14. |
Kyprianon N, Isaacs JT. Relationship between metastatic ability and Hras ocogene expression in rat mammary cancer cells transfected with the vHras oncogene. Cancer Res, 1990; 50(5)∶1449.
|
15. |
Jerry DJ, Ozbun MA, Kittrell FS, et al. Mutations in p53 are frequent in the preneopplastic stage of mouse mammary tumor development. Cancer Res, 1993; 53(14)∶3374.
|
16. |
Ozbun MA, Jerry DJ, Kittrell FS, et al. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Cancer Res, 1993; 53(7)∶1646.
|
17. |
Zusman I, Gurevich P, Madar Z, et al. Tumorpromoting and tumorprotective effects of highfat diets on chmically induced mammary cancer in rats. Anticancer Res, 1997; 17(1A)∶349.
|
18. |
Haag JD, Hsu LC, Newton MA, et al. Allelic imbalance in mammary carcinomas induced by either 7, 12dimethylbenz [a] anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Mol Carcinog, 1996; 17(3)∶134.
|
19. |
Isaacs JT. A mammary cancer suppressor gene and its site of action in the rat. Cancer Res, 1991; 15(6)∶1591.
|
20. |
Hus LC, Kenean WS, Shepel LA, et al. Genetic identification of Mcs1, a rat mammary carcinoma supressor gene. Cancer Res, 1994; 54(10)∶2765.
|
21. |
Haag JD, Newton MA, Could NM. Mammary carcinoma suppressor and susceptibility gene in the WistarKyoto rat. Carcinogenesis, 1992; 13(10)∶1933.
|
22. |
Huynh H, Alpert L, Pollak M. Pregnancydependent growth of mammary tumors is associated with overexpression of insulinlike growth factor Ⅱ. Cancer Res, 1996; 56(16)∶3651.
|
23. |
Mizukami Y, Nonomura A, Noguchi M, et al. Effects of high and low dietary fat and indomethacin on tumor growth, hormone receptor status and growth factor expression in DMBAinduced rat breast cancer. Int J Tissue React, 1992; 14(6)∶269.
|
24. |
Coffey RJ Jr, Meise KS, Matsui Y, et al. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7, 12dimethylbenzanthracene. Cancer Res, 1994; 54(7)∶1678.
|
25. |
Lu J, Pei H, Kaeck M, et al. Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog, 1997; 20(2)∶204.
|
26. |
Heflich RH, Mittelstaedt RA, Manjanatha MG, et al. DNA sequence analysis of hprt mutations in lymphocytes from SpragueDawley rats treated with 7, 12dimethylbenz [a] anthracene. Environ Mol Mutagen, 1996; 28(1)∶5.
|
27. |
Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis, 1997; 18(9)∶1799.
|
28. |
Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat, 1996; 39(1)∶7.
|
29. |
Hilakivi CL. Maternal handling during pregnancy reduces DMBAinduced mammary tumor igenesis among female off spring. Br J Cancer, 1997; 76(2)∶150.
|